EYEN: Some detailed coverage of the company. The following is a "buried gem", IMO, about the optejet, "The Optejet micro-array print delivery platform is not regulated as a medical device or drug-device combination, which streamlines the therapeutic registration process."
Eyenovia micro-array print therapeutics targeting various ophthalmic indications
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.